(Last updated : 2024-03-11 15:22:00)
  風間 啓至
   Department   School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine  
   Position   Assistant Professor
■ Published papers
1. Original article  Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes. 2024/02/27
2. Case report  Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports. 2021/09
3. Other  Study of the asymptomatic persons' specificity of reverse transcription polymerase chain reaction for the diagnosis of coronavirus disease (COVID-19) 2021/07
4. Original article  Clinical features of patients positive for SARS-CoV-2 by RT-PCR in a fever clinic for COVID-19; Comparison with negative PCR cases and comparison of the first and second waves. 2021/01
5. Original article  Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients. 2020/04
Display all(11)